Effects of Immediate Aversive Stimulation on Haloperidol-Induced Catalepsy in Rats.
D2 antagonist
Parkinson’s disease
animal model
anxiety
dopamine
emotional state
paradoxical kinesia
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
01
2022
accepted:
17
03
2022
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
In animal models, the administration of the dopaminergic D2 antagonist haloperidol affects the nigrostriatal pathway, inducing catalepsy, a state of immobility similar to Parkinson's disease (PD) bradykinesia and akinesia. In PD, the motor impairments are due to difficulties in selecting and executing motor actions, associated with dopamine loss in basal ganglia and cortical targets. Motor and affective limbic networks seem to be integrated
Identifiants
pubmed: 35481243
doi: 10.3389/fnbeh.2022.867180
pmc: PMC9036068
doi:
Types de publication
Journal Article
Langues
eng
Pagination
867180Informations de copyright
Copyright © 2022 Waku, Reimer and de Oliveira.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Behav Pharmacol. 2019 Apr;30(2 and 3-Spec Issue):229-238
pubmed: 30632994
PLoS One. 2020 Dec 4;15(12):e0243438
pubmed: 33275614
Rom J Morphol Embryol. 2016;57(2):477-81
pubmed: 27516021
PLoS One. 2015 Aug 18;10(8):e0135149
pubmed: 26284366
Exp Brain Res. 2021 Jun;239(6):1963-1974
pubmed: 33885919
Science. 2001 Aug 10;293(5532):1164-6
pubmed: 11498597
Mov Disord. 1999 Jan;14(1):63-8
pubmed: 9918346
JAMA Neurol. 2019 Jun 1;76(6):718-725
pubmed: 30907948
Behav Neural Biol. 1984 Sep;42(1):38-51
pubmed: 6508692
Brain Res Bull. 2009 Feb 16;78(2-3):69-74
pubmed: 18950692
Postgrad Med J. 2001 Feb;77(904):89-93
pubmed: 11161073
Parkinsonism Relat Disord. 2003 Aug;9 Suppl 2:S65-71
pubmed: 12915070
Ann Neurol. 2001 Mar;49(3):298-303
pubmed: 11261503
Exp Brain Res. 2017 Feb;235(2):429-436
pubmed: 27766352
Trends Neurosci. 1991 Nov;14(11):480-2
pubmed: 1726761
Behav Brain Res. 2009 May 16;199(2):271-7
pubmed: 19111792
Brain. 1999 Jul;122 ( Pt 7):1271-82
pubmed: 10388793
Psychopharmacology (Berl). 2012 Sep;223(2):191-7
pubmed: 22526536
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
pubmed: 22908195
Brain Res. 2010 Aug 19;1349:41-7
pubmed: 20558148
Acta Neurobiol Exp (Wars). 2017;77(1):106-112
pubmed: 28379221
J Neurosci Methods. 2009 Sep 15;182(2):266-71
pubmed: 19559052
Brain Res. 1980 May 12;189(2):544-9
pubmed: 7370790
Mov Disord. 2010 Jul 15;25(9):1302-4
pubmed: 20310034
Eur J Pharmacol. 2003 Feb 28;463(1-3):55-65
pubmed: 12600702
Mov Disord. 2021 May;36(5):1115-1118
pubmed: 33656203
Neurobiol Learn Mem. 2011 Jan;95(1):37-45
pubmed: 20955808
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222
pubmed: 11983801
Neuroscience. 2016 Oct 15;334:160-165
pubmed: 27495877
J Med Chem. 2011 Jun 9;54(11):3866-74
pubmed: 21534547
Neuroscience. 2014 Mar 7;261:195-206
pubmed: 24384225
J Neurochem. 1989 May;52(5):1655-8
pubmed: 2709017
Basal Ganglia. 2015 Aug 1;5(2-3):51-55
pubmed: 26251824
Bioinspir Biomim. 2018 Sep 04;13(6):061001
pubmed: 30109860
Adv Exp Med Biol. 2014;826:55-68
pubmed: 25330885
Pharmacol Biochem Behav. 2004 Oct;79(2):359-65
pubmed: 15501313
Exp Neurol. 2022 Feb;348:113926
pubmed: 34793784
FEBS Lett. 2015 Nov 14;589(22):3433-7
pubmed: 25783771
Brain Imaging Behav. 2022 Jun;16(3):1349-1361
pubmed: 35020124
Behav Pharmacol. 2013 Aug;24(4):264-74
pubmed: 23751519
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:60-7
pubmed: 26343307
J Pharmacol Exp Ther. 2010 Mar;332(3):1064-71
pubmed: 19940105
Brain Res. 1980 Nov 10;201(1):143-72
pubmed: 7191346
Behav Brain Res. 2013 Nov 15;257:201-7
pubmed: 24120401
Indian J Exp Biol. 2009 Feb;47(2):91-7
pubmed: 19374163
J Neurophysiol. 2017 Nov 1;118(5):2549-2567
pubmed: 28794196
Neuroscience. 2003;119(1):293-308
pubmed: 12763089
Nat Rev Neurosci. 2002 Dec;3(12):932-42
pubmed: 12461550
Behav Neurosci. 1988 Oct;102(5):748-59
pubmed: 2904271
Pharmacol Biochem Behav. 1980 Aug;13(2):167-70
pubmed: 6106204
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Pharmacol Biochem Behav. 2015 Feb;129:111-5
pubmed: 25532461
Front Immunol. 2018 Sep 21;9:2009
pubmed: 30298064
Mov Disord. 2010 May 15;25(7):838-45
pubmed: 20461800
Behav Brain Res. 2015 Feb 15;279:1-8
pubmed: 25446814
Mov Disord. 2013 Dec;28(14):2027-32
pubmed: 24150979
Pharmacol Biochem Behav. 2006 May;84(1):102-11
pubmed: 16780936
Brain Res. 1979 Nov 2;176(2):385-90
pubmed: 497813
Cereb Cortex. 2004 Jan;14(1):73-80
pubmed: 14654458
Neurosci Lett. 2008 Dec 3;446(2-3):112-6
pubmed: 18835326
Brain Res. 1983 Nov 21;279(1-2):159-70
pubmed: 6640335
Mov Disord. 2016 Aug;31(8):1125-33
pubmed: 27125963
Neurosci Biobehav Rev. 2005;29(8):1299-311
pubmed: 16084589
Neuropharmacology. 2003 Sep;45(4):493-503
pubmed: 12907310
J Neurosci. 2009 Sep 30;29(39):12236-43
pubmed: 19793982
Exp Brain Res. 1996 May;109(2):268-76
pubmed: 8738375
Brain. 2005 Jun;128(Pt 6):1314-22
pubmed: 15716302
Mov Disord. 2007 Dec;22(16):2394-7
pubmed: 17914720
Behav Brain Res. 2010 Dec 25;214(2):402-8
pubmed: 20600344
Trends Neurosci. 2007 May;30(5):194-202
pubmed: 17408759
Nat Rev Neurosci. 2010 Nov;11(11):760-72
pubmed: 20944662
Neurosci Biobehav Rev. 2004 May;28(3):285-305
pubmed: 15225972
Lancet. 1998 Jun 13;351(9118):1801-4
pubmed: 9635969
Neuropharmacology. 2018 Jun;135:172-179
pubmed: 29550392
Behav Brain Res. 2018 Jan 30;337:204-209
pubmed: 28916501
Br J Pharmacol. 2011 Oct;164(4):1357-91
pubmed: 21486284
Exp Brain Res. 2017 Aug;235(8):2329-2348
pubmed: 28478576
Trends Pharmacol Sci. 1992 Mar;13(3):116-21
pubmed: 1349447
Neuropsychopharmacology. 2001 Nov;25(5):633-41
pubmed: 11682246
J Biomech. 2010 Dec 1;43(16):3099-103
pubmed: 20828698
Eur J Neurosci. 2021 Jun;53(11):3743-3767
pubmed: 33818841
Arch Neurol. 1989 Oct;46(10):1070-5
pubmed: 2508609
PLoS One. 2014 Aug 18;9(8):e104228
pubmed: 25133693
J Neural Transm Park Dis Dement Sect. 1993;6(1):17-26
pubmed: 8216760
Neurosci Res. 2004 Oct;50(2):137-51
pubmed: 15380321
Neuroscience. 2012 Sep 6;219:72-81
pubmed: 22698693